Enbrel (etanercept) - all formulations - Revised SPC
Source: eMC (electronic Medicines Compendium)
Area: Other Library Updates > SPC Changes
Section 4.8 (undesirable effects) of the SPC has been updated to include Hepatitis B reactivation as an adverse reaction of unknown prevalence.
Hepatitis B is included in the list of serious infections that occurred in 6.3% of rheumatoid arthritis patients treated with Enbrel for up to 48 months.
Please see seperate SPC links for full prescribing information.
Source: NeLM - SPC Changes - Category: Drugs & Pharmacology Source Type: news
More News: Arthritis | Databases & Libraries | Drugs & Pharmacology | Enbrel | Hepatitis | Hepatitis B | Rheumatoid Arthritis | Rheumatology